Is Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) Still On The Rise?

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Crinetics Pharmaceuticals Inc is $3.73B. A total of 0.74 million shares were traded on the day, compared to an average of 826.88K shares.

In the most recent transaction, Pizzuti Dana sold 15,000 shares of CRNX for 52.09 per share on Jan 03 ’25. After the transaction, the Chief Med and Dev Officer now owns 29,248 company shares. In a previous transaction on Jan 03 ’25, DANA J PIZZUTI bought 15,000 shares at 52.09 per share.

Among the insiders who sold shares, Struthers Richard Scott disposed of 10,000 shares on Dec 02 ’24 at a per-share price of $57.57. This resulted in the President & CEO holding 100,000 shares of CRNX after the transaction. In another insider transaction, Struthers Richard Scott bought 10,000 shares at $57.27 per share on Dec 02 ’24.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, CRNX has a high of $62.53 and a low of $35.51.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. CRNX’s latest balance sheet shows that the firm has $333.71M in Cash & Short Term Investments as of fiscal 2021. There were $3.07M in debt and $15.99M in liabilities at the time. Its Book Value Per Share was $10.30, while its Total Shareholder’s Equity was $331.94M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRNX is Buy with a score of 5.00.

Most Popular

Related Posts